lunes, 22 de enero de 2018

FDA approves olaparib for germline BRCA-mutated metastatic breast cancer

Main|Search|PHGKB

BRCA

From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

No hay comentarios:

Publicar un comentario